<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>86-BACLOFEN.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="BACLOFEN" rxcui="1292">
<ATC code="M03BX01" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="TRICYCLIC ANTIDEPRESSANTS" code="N06AA-001" /></DRUG2>
<DESCRIPTION>Risk of increase of hypotonia</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>86-BACLOFEN.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="BACLOFEN" rxcui="1292">
<ATC code="M03BX01" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="LEVODOPA" rxcui="6375">
<ATC code="N04BA01" />
<ATC code="N04BA02" />
<ATC code="N04BA03" />
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of aggravation of the Parkinson&#146;s syndrome or of undesirable central effects (visual hallucinations, confusion, headaches)</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
</INTERACTIONS>
